OBJECTIVE: Cross-sectional studies have observed that muscle weakness is associated with worse physical function among women with systemic lupus erythematosus (SLE). The present study examines whether reduced upper and lower extremity muscle strength predict declines in function over time among adult women with SLE. METHODS: One hundred forty-six women from a longitudinal SLE cohort participated in the study. All measures were collected during in-person research visits approximately 2 years apart. Upper extremity muscle strength was assessed by grip strength. Lower extremity muscle strength was assessed by peak knee torque of extension and flexion. Physical function was assessed using the Short Physical Performance Battery (SPPB). Regression analyses modeled associations of baseline upper and lower extremity muscle strength with followup SPPB scores controlling for baseline SPPB, age, SLE duration, SLE disease activity (Systemic Lupus Activity Questionnaire), physical activity level, prednisone use, body composition, and depression. Secondary analyses tested whether associations of baseline muscle strength with followup in SPPB scores differed between intervals of varying baseline muscle strength. RESULTS: Lower extremity muscle strength strongly predicted changes over 2 years in physical function even when controlling for covariates. The association of reduced lower extremity muscle strength with reduced physical function in the future was greatest among the weakest women. CONCLUSION: Reduced lower extremity muscle strength predicted clinically significant declines in physical function, especially among the weakest women. Future studies should test whether therapies that promote preservation of lower extremity muscle strength may prevent declines in function among women with SLE.
OBJECTIVE: Cross-sectional studies have observed that muscle weakness is associated with worse physical function among women with systemic lupus erythematosus (SLE). The present study examines whether reduced upper and lower extremity muscle strength predict declines in function over time among adult women with SLE. METHODS: One hundred forty-six women from a longitudinal SLE cohort participated in the study. All measures were collected during in-person research visits approximately 2 years apart. Upper extremity muscle strength was assessed by grip strength. Lower extremity muscle strength was assessed by peak knee torque of extension and flexion. Physical function was assessed using the Short Physical Performance Battery (SPPB). Regression analyses modeled associations of baseline upper and lower extremity muscle strength with followup SPPB scores controlling for baseline SPPB, age, SLE duration, SLE disease activity (Systemic Lupus Activity Questionnaire), physical activity level, prednisone use, body composition, and depression. Secondary analyses tested whether associations of baseline muscle strength with followup in SPPB scores differed between intervals of varying baseline muscle strength. RESULTS: Lower extremity muscle strength strongly predicted changes over 2 years in physical function even when controlling for covariates. The association of reduced lower extremity muscle strength with reduced physical function in the future was greatest among the weakest women. CONCLUSION: Reduced lower extremity muscle strength predicted clinically significant declines in physical function, especially among the weakest women. Future studies should test whether therapies that promote preservation of lower extremity muscle strength may prevent declines in function among women with SLE.
Authors: M L A S Santos; W F Gomes; D S Pereira; D M G Oliveira; J M D Dias; E Ferrioli; L S M Pereira Journal: Arch Gerontol Geriatr Date: 2011 May-Jun Impact factor: 3.250
Authors: Marjolein Visser; Stephen B Kritchevsky; Bret H Goodpaster; Anne B Newman; Michael Nevitt; Elizabeth Stamm; Tamara B Harris Journal: J Am Geriatr Soc Date: 2002-05 Impact factor: 5.562
Authors: Bret H Goodpaster; Seok Won Park; Tamara B Harris; Steven B Kritchevsky; Michael Nevitt; Ann V Schwartz; Eleanor M Simonsick; Frances A Tylavsky; Marjolein Visser; Anne B Newman Journal: J Gerontol A Biol Sci Med Sci Date: 2006-10 Impact factor: 6.053
Authors: E W Karlson; L H Daltroy; C Rivest; R Ramsey-Goldman; E A Wright; A J Partridge; M H Liang; P R Fortin Journal: Lupus Date: 2003 Impact factor: 2.911
Authors: James S Andrews; Laura Trupin; Catherine L Hough; David I Daikh; Edward H Yelin; Patricia P Katz Journal: Cytokine Date: 2016-11-16 Impact factor: 3.861
Authors: James S Andrews; Laura Trupin; Edward H Yelin; Catherine L Hough; Kenneth E Covinsky; Patricia P Katz Journal: Clin Rheumatol Date: 2017-01-23 Impact factor: 2.980
Authors: Blanca Gavilán-Carrera; Jaqueline Garcia da Silva; José A Vargas-Hitos; José M Sabio; Pablo Morillas-de-Laguno; Raquel Rios-Fernández; Manuel Delgado-Fernández; Alberto Soriano-Maldonado Journal: PLoS One Date: 2019-02-20 Impact factor: 3.240
Authors: Kristin Schink; Hans J Herrmann; Raphaela Schwappacher; Julia Meyer; Till Orlemann; Elisabeth Waldmann; Bernd Wullich; Andreas Kahlmeyer; Rainer Fietkau; Dorota Lubgan; Matthias W Beckmann; Carolin Hack; Wolfgang Kemmler; Jürgen Siebler; Markus F Neurath; Yurdagül Zopf Journal: BMC Cancer Date: 2018-09-12 Impact factor: 4.430